AGP Executive Report
Last update: 8 hours agoVirtual cardiac follow-ups: Dalhousie-led ESC Congress trials report VIRTUES virtual e-health monitoring for pacemakers and ICDs was as safe/effective as standard care, with potential cost savings and higher patient satisfaction. Imaging upgrades in Saskatchewan: New StarGuide scanners at Regina General and Royal University Hospital are delivering sharper SPECT/CT images in shorter appointments, with thousands of patients already scanned. Gene therapy progress: AskBio presented baseline results from the Phase 2 GenePHIT heart-failure gene therapy trial, with enrollment completed across 64 sites and early outcomes expected in 2027. Sweetener safety signal: A new ESC Congress study links higher blood xylitol levels to higher stroke, heart attack and death risk, raising questions for low-calorie sweetener use. Obesity care partnership: Obesity Canada launched a partnership aimed at improving obesity prevention and treatment in Alberta’s health system. Health-tech investment: Xanadu Quantum Technologies received $195M in federal repayable funding to advance photonic quantum computing with potential spillovers into medical science. Care access and equity: Coverage highlights ongoing gaps in mental health supports and the need for better emergency readiness, including mental health planning.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
